找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊Onkologie 2024/2025影响因子:0.249 (ONKOLOGIE-GER) (2731-7226). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded  ...234
Total Citations:233; 2023 JIF:0.249; JIFRank: 315/322 ; Rank-JIF: 315; Number-of-JIF:322; 5 Year JIF:0.244; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:0.1; Immediacy Index-dealt:0.115; 2023 JCI:0.07; JCI Rank: 311/322 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:3.57; Eigenfactor:0; Normalized Eigenfactor:0.049; Article Influence Score:0.042; JIF Percentile:2.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:111; % of Articles in Citable items:0.9279; Cited Half-Life:4.5; Citing Half-Life:5.5; % of OA Gold:0.0941; Publisher name:SPRINGERNATURE; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊Radiology and Oncology 2024/2025影响因子:2.162 (RADIOL ONCOL) (1318-2099). (ONCOLOGY)(肿瘤学)Science Citation Index Expa  ...234
Total Citations:1502; 2023 JIF:2.162; JIFRank: 214/322 ; Rank-JIF: 214; Number-of-JIF:322; 5 Year JIF:2.822; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2; Immediacy Index:0.3; Immediacy Index-dealt:0.375; 2023 JCI:0.56; JCI Rank: 192/322 ; Total Articles:51; JCI Quartile:Q3; JCI Percentile:45.83; Eigenfactor:0.001; Normalized Eigenfactor:0.318; Article Influence Score:0.588; JIF Percentile:53.2; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:60; % of Articles in Citable items:0.85; Cited Half-Life:4.9; Citing Half-Life:7.5; % of OA Gold:0.9781; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN
投票 SCIE期刊CANCER SCIENCE 2024/2025影响因子:4.598 (CANCER SCI) (1347-9032). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded  ...234
Total Citations:19851; 2023 JIF:4.598; JIFRank: 78/322 ; Rank-JIF: 78; Number-of-JIF:322; 5 Year JIF:5.522; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.4; Immediacy Index:0.8; Immediacy Index-dealt:0.865; 2023 JCI:1.01; JCI Rank: 79/322 ; Total Articles:292; JCI Quartile:Q1; JCI Percentile:75.62; Eigenfactor:0.021; Normalized Eigenfactor:4.689; Article Influence Score:1.335; JIF Percentile:75.9; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:316; % of Articles in Citable items:0.9241; Cited Half-Life:5.5; Citing Half-Life:6.4; % of OA Gold:0.7361; Publisher name:LIBRAIRIE DROZ SA; Publisher address:11 RUE MASSOT CASE POSTALE 389, GENEVA
投票 SCIE期刊CANCER AND METASTASIS REVIEWS 2024/2025影响因子:7.754 (CANCER METAST REV) (0167-7659). (ONCOLOGY)(肿瘤学)Science Citatio  ...234
Total Citations:7781; 2023 JIF:7.754; JIFRank: 37/322 ; Rank-JIF: 37; Number-of-JIF:322; 5 Year JIF:10.309; 5 Year JIF Quartile:Q1; JIF Without Self Cites:7.6; Immediacy Index:1.7; Immediacy Index-dealt:1.796; 2023 JCI:1.11; JCI Rank: 67/322 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:79.35; Eigenfactor:0.006; Normalized Eigenfactor:1.241; Article Influence Score:2.404; JIF Percentile:88.7; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:71; % of Articles in Citable items:0; Cited Half-Life:7.9; Citing Half-Life:6.8; % of OA Gold:0.431; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS, 2300 P
投票 SCIE期刊CURRENT OPINION IN ONCOLOGY 2024/2025影响因子:2.832 (CURR OPIN ONCOL) (1040-8746). (ONCOLOGY)(肿瘤学)Science Citation In  ...234
Total Citations:2958; 2023 JIF:2.832; JIFRank: 157/322 ; Rank-JIF: 157; Number-of-JIF:322; 5 Year JIF:3.139; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.6; Immediacy Index-dealt:0.663; 2023 JCI:0.45; JCI Rank: 225/322 ; Total Articles:0; JCI Quartile:Q3; JCI Percentile:30.28; Eigenfactor:0.003; Normalized Eigenfactor:0.647; Article Influence Score:0.88; JIF Percentile:51.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:78; % of Articles in Citable items:0; Cited Half-Life:7; Citing Half-Life:4.2; % of OA Gold:0.1034; Publisher name:UNIV LJUBLJANA, FAC PUBLIC ADM; Publisher address:GOSARJEVA 5, LJUBLJANA, SLOVENIA,
投票 SCIE期刊SEMINARS IN ONCOLOGY 2024/2025影响因子:3.112 (SEMIN ONCOL) (0093-7754). (ONCOLOGY)(肿瘤学)Science Citation Index Expande  ...234
Total Citations:4587; 2023 JIF:3.112; JIFRank: 142/322 ; Rank-JIF: 142; Number-of-JIF:322; 5 Year JIF:4.181; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.5; Immediacy Index-dealt:0.562; 2023 JCI:0.4; JCI Rank: 241/322 ; Total Articles:0; JCI Quartile:Q3; JCI Percentile:25.31; Eigenfactor:0.002; Normalized Eigenfactor:0.465; Article Influence Score:1.204; JIF Percentile:56.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:23; % of Articles in Citable items:0; Cited Half-Life:11.9; Citing Half-Life:6.6; % of OA Gold:0.1619; Publisher name:PLEIADES PUBLISHING INC; Publisher address:PLEIADES HOUSE, 7 W 54 ST, NEW YORK, U
投票 SCIE期刊BREAST CANCER RESEARCH AND TREATMENT 2024/2025影响因子:3.186 (BREAST CANCER RES TR) (0167-6806). (ONCOLOGY)(肿瘤学)Scien  ...234
Total Citations:22703; 2023 JIF:3.186; JIFRank: 142/322 ; Rank-JIF: 142; Number-of-JIF:322; 5 Year JIF:3.993; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.5; Immediacy Index-dealt:0.567; 2023 JCI:0.73; JCI Rank: 135/322 ; Total Articles:308; JCI Quartile:Q2; JCI Percentile:58.23; Eigenfactor:0.022; Normalized Eigenfactor:4.754; Article Influence Score:1.223; JIF Percentile:56.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:328; % of Articles in Citable items:0.939; Cited Half-Life:8.2; Citing Half-Life:7; % of OA Gold:0.3177; Publisher name:UNIV AUSTRAL, FAC COMUNICACION; Publisher address:CERRITO 1250, CABA MARIAN
投票 SCIE期刊MOLECULAR CANCER THERAPEUTICS 2024/2025影响因子:5.386 (MOL CANCER THER) (1535-7163). (ONCOLOGY)(肿瘤学)Science Citation  ...234
Total Citations:18993; 2023 JIF:5.386; JIFRank: 61/322 ; Rank-JIF: 61; Number-of-JIF:322; 5 Year JIF:5.447; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.3; Immediacy Index:1.2; Immediacy Index-dealt:1.285; 2023 JCI:1.23; JCI Rank: 58/322 ; Total Articles:104; JCI Quartile:Q1; JCI Percentile:82.14; Eigenfactor:0.016; Normalized Eigenfactor:3.426; Article Influence Score:1.727; JIF Percentile:81.2; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:116; % of Articles in Citable items:0.8966; Cited Half-Life:8.6; Citing Half-Life:7.1; % of OA Gold:0.3275; Publisher name:VERLAG OTTO HARRASSOWITZ; Publisher address:TAUMUSSTR 14,, WIESBADEN, GERMA
投票 SCIE期刊Current Oncology Reports 2024/2025影响因子:4.726 (CURR ONCOL REP) (1523-3790). (ONCOLOGY)(肿瘤学)Science Citation Index  ...234
Total Citations:4869; 2023 JIF:4.726; JIFRank: 73/322 ; Rank-JIF: 73; Number-of-JIF:322; 5 Year JIF:5.120; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.7; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:0.68; JCI Rank: 151/322 ; Total Articles:0; JCI Quartile:Q2; JCI Percentile:53.26; Eigenfactor:0.007; Normalized Eigenfactor:1.618; Article Influence Score:1.347; JIF Percentile:77.5; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:125; % of Articles in Citable items:0; Cited Half-Life:4.3; Citing Half-Life:5.2; % of OA Gold:0.2267; Publisher name:MARY ANN LIEBERT, INC; Publisher address:140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE
投票 SCIE期刊Trends in Cancer 2024/2025影响因子:14.358 (TRENDS CANCER) (2405-8025). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded  ...234
Total Citations:7958; 2023 JIF:14.358; JIFRank: 17/322 ; Rank-JIF: 17; Number-of-JIF:322; 5 Year JIF:17.181; 5 Year JIF Quartile:Q1; JIF Without Self Cites:14.2; Immediacy Index:4.1; Immediacy Index-dealt:4.162; 2023 JCI:2.14; JCI Rank: 24/322 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:92.7; Eigenfactor:0.015; Normalized Eigenfactor:3.332; Article Influence Score:5.608; JIF Percentile:94.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:66; % of Articles in Citable items:0; Cited Half-Life:3.9; Citing Half-Life:5.3; % of OA Gold:0.4259; Publisher name:CHARLES UNIV PRAGUE, FAC ARTS; Publisher address:NAM JANA PALACHA 2, PRAGUE, CZECH
投票 SCIE期刊ORAL ONCOLOGY 2024/2025影响因子:4.163 (ORAL ONCOL) (1368-8375). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded  ...234
Total Citations:13287; 2023 JIF:4.163; JIFRank: 95/322 ; Rank-JIF: 95; Number-of-JIF:322; 5 Year JIF:4.629; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.8; Immediacy Index:0.7; Immediacy Index-dealt:0.764; 2023 JCI:1.18; JCI Rank: 62/322 ; Total Articles:133; JCI Quartile:Q1; JCI Percentile:80.9; Eigenfactor:0.012; Normalized Eigenfactor:2.68; Article Influence Score:1.199; JIF Percentile:70.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:158; % of Articles in Citable items:0.8418; Cited Half-Life:6.8; Citing Half-Life:6.1; % of OA Gold:0.1863; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊STRAHLENTHERAPIE UND ONKOLOGIE 2024/2025影响因子:2.706 (STRAHLENTHER ONKOL) (0179-7158). (ONCOLOGY)(肿瘤学)Science Citat  ...234
Total Citations:3545; 2023 JIF:2.706; JIFRank: 163/322 ; Rank-JIF: 163; Number-of-JIF:322; 5 Year JIF:2.821; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.6; Immediacy Index-dealt:0.633; 2023 JCI:0.73; JCI Rank: 135/322 ; Total Articles:93; JCI Quartile:Q2; JCI Percentile:58.09; Eigenfactor:0.003; Normalized Eigenfactor:0.624; Article Influence Score:0.614; JIF Percentile:66.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:110; % of Articles in Citable items:0.8455; Cited Half-Life:6.7; Citing Half-Life:6.5; % of OA Gold:0.5823; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 SCIE期刊CANCER INVESTIGATION 2024/2025影响因子:1.818 (CANCER INVEST) (0735-7907). (ONCOLOGY)(肿瘤学)Science Citation Index Expan  ...234
Total Citations:2543; 2023 JIF:1.818; JIFRank: 241/322 ; Rank-JIF: 241; Number-of-JIF:322; 5 Year JIF:2.11; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.7; Immediacy Index-dealt:0.743; 2023 JCI:0.39; JCI Rank: 246/322 ; Total Articles:44; JCI Quartile:Q4; JCI Percentile:23.76; Eigenfactor:0.001; Normalized Eigenfactor:0.109; Article Influence Score:0.484; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:53; % of Articles in Citable items:0.8302; Cited Half-Life:11.8; Citing Half-Life:6.1; % of OA Gold:0.0762; Publisher name:GEORG THIEME VERLAG KG; Publisher address:RUDIGERSTR 14, STUTTGART, GERMANY
投票 SCIE期刊Oncology Research and Treatment 2024/2025影响因子:2.128 (ONCOL RES TREAT) (2296-5270). (ONCOLOGY)(肿瘤学)Science Citatio  ...234
Total Citations:1285; 2023 JIF:2.128; JIFRank: 221/322 ; Rank-JIF: 221; Number-of-JIF:322; 5 Year JIF:2.235; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.3; Immediacy Index-dealt:0.391; 2023 JCI:0.4; JCI Rank: 241/322 ; Total Articles:45; JCI Quartile:Q3; JCI Percentile:25.31; Eigenfactor:0.002; Normalized Eigenfactor:0.418; Article Influence Score:0.602; JIF Percentile:31.5; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:51; % of Articles in Citable items:0.8824; Cited Half-Life:4.9; Citing Half-Life:5.1; % of OA Gold:0.1765; Publisher name:EMERALD GROUP PUBLISHING LTD; Publisher address:Floor 5, Northspring 21-23 W
投票 SCIE期刊Journal for ImmunoTherapy of Cancer 2024/2025影响因子:10.388 (J IMMUNOTHER CANCER) (NULL). (ONCOLOGY)(肿瘤学)Science Cit  ...234
Total Citations:26773; 2023 JIF:10.388; JIFRank: 26/322 ; Rank-JIF: 26; Number-of-JIF:322; 5 Year JIF:11.689; 5 Year JIF Quartile:Q1; JIF Without Self Cites:10; Immediacy Index:1.7; Immediacy Index-dealt:1.741; 2023 JCI:2.01; JCI Rank: 29/322 ; Total Articles:391; JCI Quartile:Q1; JCI Percentile:91.15; Eigenfactor:0.061; Normalized Eigenfactor:13.286; Article Influence Score:3.597; JIF Percentile:92.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:417; % of Articles in Citable items:0.9376; Cited Half-Life:3.3; Citing Half-Life:5.3; % of OA Gold:0.9898; Publisher name:IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC; Publisher address:445 HOE
投票 SCIE期刊JOURNAL OF RADIATION RESEARCH 2024/2025影响因子:1.919 (J RADIAT RES) (0449-3060). (ONCOLOGY)(肿瘤学)Science Citation Ind  ...234
Total Citations:3327; 2023 JIF:1.919; JIFRank: 234/322 ; Rank-JIF: 234; Number-of-JIF:322; 5 Year JIF:2.101; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.8; Immediacy Index:0.2; Immediacy Index-dealt:0.247; 2023 JCI:0.5; JCI Rank: 208/322 ; Total Articles:109; JCI Quartile:Q3; JCI Percentile:35.56; Eigenfactor:0.002; Normalized Eigenfactor:0.501; Article Influence Score:0.468; JIF Percentile:27.5; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:113; % of Articles in Citable items:0.9646; Cited Half-Life:8.2; Citing Half-Life:8.8; % of OA Gold:0.9272; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 SCIE期刊ANTICANCER RESEARCH 2024/2025影响因子:1.642 (ANTICANCER RES) (0250-7005). (ONCOLOGY)(肿瘤学)Science Citation Index Expan  ...234
Total Citations:21152; 2023 JIF:1.642; JIFRank: 253/322 ; Rank-JIF: 253; Number-of-JIF:322; 5 Year JIF:1.897; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.5; Immediacy Index-dealt:0.562; 2023 JCI:0.42; JCI Rank: 232/322 ; Total Articles:589; JCI Quartile:Q3; JCI Percentile:28.11; Eigenfactor:0.013; Normalized Eigenfactor:2.802; Article Influence Score:0.395; JIF Percentile:21.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:637; % of Articles in Citable items:0.9246; Cited Half-Life:8.1; Citing Half-Life:7; % of OA Gold:0.2051; Publisher name:MINERALOGICAL SOC AMER; Publisher address:3635 CONCORDE PKWY STE 500, CHAN
投票 SCIE期刊CANCER GENE THERAPY 2024/2025影响因子:4.817 (CANCER GENE THER) (0929-1903). (ONCOLOGY)(肿瘤学)Science Citation Index Exp  ...234
Total Citations:4575; 2023 JIF:4.817; JIFRank: 70/322 ; Rank-JIF: 70; Number-of-JIF:322; 5 Year JIF:4.938; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.7; Immediacy Index:0.9; Immediacy Index-dealt:0.982; 2023 JCI:1.1; JCI Rank: 69/322 ; Total Articles:105; JCI Quartile:Q1; JCI Percentile:81.41; Eigenfactor:0.005; Normalized Eigenfactor:1.017; Article Influence Score:1.134; JIF Percentile:85.1; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:123; % of Articles in Citable items:0.8537; Cited Half-Life:4.1; Citing Half-Life:6; % of OA Gold:0.3711; Publisher name:ERNST & SOHN; Publisher address:ROTHERSTRASSE 21, BERLIN, GERMANY, DEUTSCHLAND,
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-2 05:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块